Status:
COMPLETED
COVID-19 and Reorganisation of Cancer Patient Care: Self- Evaluation of Potential Post-traumatic Stress Disorder
Lead Sponsor:
Institut Paoli-Calmettes
Conditions:
Cancer
Eligibility:
All Genders
18+ years
Phase:
NA
Brief Summary
The COVID-19 pandemic is a traumatic event which could lead to a greater risk of developing post-traumatic stress disorder, especially in cancer patients who feel more at risk of contracting the virus...
Eligibility Criteria
Inclusion
- Man or woman, age\>18
- Diagnosis of cancer (solid tumor or hematology)
- Out patient or patient Under surveillance
Exclusion
- Refusal to participate in the study
- Emergency, person deprived of liberty
- hospitalized patient
Key Trial Info
Start Date :
May 20 2020
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
February 2 2021
Estimated Enrollment :
1096 Patients enrolled
Trial Details
Trial ID
NCT04401046
Start Date
May 20 2020
End Date
February 2 2021
Last Update
July 22 2021
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Institut Paoli-Calmettes
Marseille, France, 13273